The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer

Journal of Sexual Medicine

Volumn 5, Issue 4, 2008, Pages 919-927

  Karakiewicz, Pierre I ^a   Bhojani, Naeem ^b   Neugut, Alfred ^c   Shariat, Shahrokh F ^d   Jeldres, Claudio ^b   Graefen, Markus ^e   Perrotte, Paul ^a   Peloquin, Francois ^b   Kattan, Michael W ^f  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF HAMBURG   (Germany)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Comorbidity; Health Related Quality of Life; Radical Prostatectomy; Sexual Function; Socioeconomic Status; Urinary Function

Indexed keywords

ADULT; AGED; ALCOHOLISM; AMPUTATION; ARTICLE; ASTHMA; CANADA; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ABUSE; HEART INFARCTION; HUMAN; KIDNEY DISEASE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; SEIZURE; SEXUAL FUNCTION; SOCIAL STATUS; SOCIOECONOMICS; STOMACH ULCER; UNIVARIATE ANALYSIS; URINARY TRACT FUNCTION;

EID: 41549154694     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00741.x     Document Type: Article

References (26)

1. Nelson CJ, Choi JM, Mulhall JP, Roth AJ. Determinants of sexual satisfaction in men with prostate cancer. J Sex Med 2007; 4: 1422-7.
2. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA 1993; 269: 2650-8.
3. Garos S, Kluck A, Aronoff D. Prostate cancer patients and their partners: Differences in satisfaction indices and psychological variables. J Sex Med 2007; 4: 1394-403.
4. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129-35.
5. Perez MA, Meyerowitz BE, Lieskovsky G, Skinner DG, Reynolds B, Skinner EC. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids. Urology 1997; 50: 740-6.
6. Leandri P, Rossignol G, Gautier JR, Ramon J. Radical retropubic prostatectomy: Morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992; 147: 883-7.
7. Lee WR, McQuellon RP, Harris-Henderson K, Case LD, McCullough DL. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2000; 46: 77-81.
8. Dayal HH, Polissar L, Dahlberg S. Race, socioeconomic status, and other prognostic factors for survival from prostate cancer. J Natl Cancer Inst 1985; 74: 1001-6.
9. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280: 975-80.
10. Fowler JE Jr, Terrell FL, Renfroe DL. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol 1996; 156: 1714-8.
11. Greenfield S. Case mix: Effect on health outcome assessment, with examples in the outpatient setting. Clin Perform Qual Health Care 1996; 4: 214-5.
12. Greenfield S, Sullivan L, Dukes KA, Silliman R, D'Agostino R, Kaplan SH. Development and testing of a new measure of case mix for use in office practice. Med Care 1995; 33: AS47 -55.
13. Karakiewicz PI, Kattan MW, Tanguay S, Elhilali MM, Bazinet M, Scardino PT, Aprikian AG. Cross-cultural validation of the UCLA prostate cancer index. Urology 2003; 61: 302-7.
14. Litwin MS, Lubeck DP, Stoddard ML, Pasta DJ, Flanders SC, Henning JM. Quality of life before death for men with prostate cancer: Results from the CaPSURE database. J Urol 2001; 165: 871-5.
15. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 2000; 283: 354-60.
16. Brandeis JM, Litwin MS, Burnison CM, Reiter RE. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 2000; 163: 851-7.
17. Litwin MS, Pasta DJ, Yu J, Stoddard ML, Flanders SC. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: A longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 2000; 164: 1973-7.
18. Mulhall JP, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med 2007; 4: 538-43.
19. Staniszewska S, Ahmed L, Jenkinson C. The conceptual validity and appropriateness of using health-related quality of life measures with minority ethnic groups. Ethn Health 1999; 4: 51-63.
20. Pfennings L, Cohen L, Miller D, Gerbaud L, Vleugels L, Freeman J, Vernay D, Biolay S, Ketelaer P, Thompson A, Polman C, van der Ploeg H. Using the Short Form-36 with multiple sclerosis patients in five countries: A cross-cultural comparison. Psychol Rep 1999; 85: 19-31.
21. Perneger TV, Leplege A, Etter JF. Cross-cultural adaptation of a psychometric instrument: Two methods compared. J Clin Epidemiol 1999; 52: 1037-46.
22. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055-68.
23. Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Clinical and psychosocial characteristics of men with erectile dysfunction: Baseline data from ExCEED. J Sex Med 2006; 3: 1059-67.
24. Legler J, Potosky AL, Gilliland FD, Eley JW, Stanford JL. Validation study of retrospective recall of disease-targeted function: Results from the prostate cancer outcomes study. Med Care 2000; 38: 847-57.
25. Ramanathan R, Mulhall J, Rao S, Leung R, Martinez Salamanca JI, Mandhani A, Tewari A. Predictive correlation between the International Index of Erectile Function (IIEF) and Sexual Health Inventory for Men (SHIM): Implications for calculating a derived SHIM for clinical use. J Sex Med 2007; 4: 1336-44.
26. Karakiewicz P, Shariat SF, Naderi A, Kadmon D, Slawin KM. Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer. Urology 2005; 65: 131-5.